1991
DOI: 10.1016/0142-9612(91)90049-g
|View full text |Cite
|
Sign up to set email alerts
|

Enzymatic degradation and immunogenic properties of derivatized dextrans

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
37
0

Year Published

1991
1991
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 51 publications
(39 citation statements)
references
References 17 publications
2
37
0
Order By: Relevance
“…The nature of modification had no significant effect on the rate of degradation. Similar results were obtained by others (ROSEMEYER and SELA 1984;CHAVES and ARRANZ 1985;CREPON et al 1991). The degradation of dextran and its derivatives with isolated lysosomal enzymes (SCHACHT et al 1988) was slower than the cleavage by dextranase.…”
Section: Principles Of Biodegr~dabilitysupporting
confidence: 88%
“…The nature of modification had no significant effect on the rate of degradation. Similar results were obtained by others (ROSEMEYER and SELA 1984;CHAVES and ARRANZ 1985;CREPON et al 1991). The degradation of dextran and its derivatives with isolated lysosomal enzymes (SCHACHT et al 1988) was slower than the cleavage by dextranase.…”
Section: Principles Of Biodegr~dabilitysupporting
confidence: 88%
“…Remarkably, biodegradable dextran hydrogels containing polyethylene glycol have exhibited regulated insulin release (138). A substantial number of pharmacokinetic studies on dextran conjugates with therapeutic and imaging agents have been carried out in animals (31,42,127,138,139).…”
Section: Clinical Applications Of Dextran and Dextranasesmentioning
confidence: 99%
“…Studies have shown that dextran resistant to enzymatic degradation and most stable in tissue environment (Crepon, Jozefonvicz, Chytry, Rihova, & Kopecek, 1991).…”
Section: Dextranmentioning
confidence: 99%